Agreement with ICM for the commercialization of the i3 test and MyDiet Genetics

Overgenes closes its first agreement with Alfonso Alba, CEO of the Institute of Molecular and Cellular Studies (ICM) for the commercialization of the intolerance tests: i3 and nutrigenetics: MyDiet Genetics. ICM is one of the main providers of genetic services for large companies such as QuirónSalud or Unilabs.

To get more information about i3 test: https://www.e-icm.net/en/precision-medicine/intolerance-test

To get more information about MyDiet Genetics: https://www.e-icm.net/en/precision-medicine/nutritional-genetic